MindBio Therapeutics Corp. (CSE:MBIO)
Canada · Delayed Price · Currency is CAD 1.250
-0.190 (-13.19%)
May 1, 2026, 1:40 PM EST
MindBio Therapeutics Market Cap
MindBio Therapeutics has a market cap or net worth of CAD 10.49 million as of May 1, 2026. Its market cap has increased by 389.08% in one year.
Market Cap
10.49M
Enterprise Value
12.10M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
1.25
Market Cap Chart
Since May 5, 2023, MindBio Therapeutics's market cap has decreased from 79.83M to 10.49M, a decrease of -86.86%. That is a compound annual growth rate of -49.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 1, 2026 | 8.89M | 48.27% |
| Dec 31, 2025 | 5.99M | 109.60% |
| Dec 31, 2024 | 2.86M | -14.04% |
| Dec 27, 2023 | 3.33M | -95.83% |
| May 5, 2023 | 79.83M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Marvel Biosciences | 10.40M |
| Glow Lifetech | 9.61M |
| COSCIENS Biopharma | 8.25M |
| PharmaTher Holdings | 7.74M |
| Kane Biotech | 6.36M |
| Aptose Biosciences | 6.05M |
| Restart Life Sciences | 5.64M |
| MYND Life Sciences | 5.22M |